Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Oncology·MeSH: Clear-cell metastatic renal cell carcinoma
Prevalence
48.0 / 100K
Incidence
15.0 / 100K/yr
4 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Advanced/Metastatic Clear Cell Renal Cell Carcinoma?
BioSniper tracks 4 drugs in development for Advanced/Metastatic Clear Cell Renal Cell Carcinoma across 1 company.
How many clinical trials target Advanced/Metastatic Clear Cell Renal Cell Carcinoma?
There are 1 clinical trial targeting Advanced/Metastatic Clear Cell Renal Cell Carcinoma tracked by BioSniper.
What is the prevalence of Advanced/Metastatic Clear Cell Renal Cell Carcinoma?
The estimated prevalence of Advanced/Metastatic Clear Cell Renal Cell Carcinoma is approximately 48.0 per 100,000 population.
Deep-dive into Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis